{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:05:40Z","timestamp":1762506340552},"reference-count":37,"publisher":"Spandidos Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.3892\/ijo.2014.2477","type":"journal-article","created":{"date-parts":[[2014,5,29]],"date-time":"2014-05-29T08:45:13Z","timestamp":1401353113000},"page":"641-650","source":"Crossref","is-referenced-by-count":9,"title":["Upregulation of FGFR1 expression is associated with parathyroid carcinogenesis in HPT-JT syndrome due to an HRPT2 splicing mutation"],"prefix":"10.3892","volume":"45","author":[{"given":"JI-YOUNG","family":"LEE","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SU YEON","family":"KIM","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"EUN-YEONG","family":"MO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"EUN-SOOK","family":"KIM","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JE-HO","family":"HAN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"LEE-SO","family":"MAENG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"AN-HEE","family":"LEE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JUNG WOO","family":"EUN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SUK WOO","family":"NAM","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SUNG-DAE","family":"MOON","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2014,5,29]]},"reference":[{"key":"key20180107181840_b1-ijo-45-02-0641","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s12672-011-0100-8","article-title":"Frequent germ-line mutations of the MEN1, CASR, and HRPT2\/CDC73 genes in young patients with clinically non-familial primary hyperparathyroidism","volume":"3","author":"Starker","year":"2012","journal-title":"Horm Cancer"},{"key":"key20180107181840_b2-ijo-45-02-0641","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/01.pap.0000151319.42376.d4","article-title":"Parathyroid carcinoma: an overview","volume":"12","author":"DeLellis","year":"2005","journal-title":"Adv Anat Pathol"},{"key":"key20180107181840_b3-ijo-45-02-0641","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1097\/01.pas.0000166368.68459.99","article-title":"Allelic loss in parathyroid neoplasia can help characterize malignancy","volume":"29","author":"Hunt","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"key20180107181840_b4-ijo-45-02-0641","doi-asserted-by":"crossref","first-page":"7405","DOI":"10.1158\/0008-5472.CAN-04-2063","article-title":"Gene expression of parathyroid tumors: molecular subclassification and identification of the potential malignant phenotype","volume":"64","author":"Haven","year":"2004","journal-title":"Cancer Res"},{"key":"key20180107181840_b5-ijo-45-02-0641","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1530\/eje.0.1480403","article-title":"Decrease in vitamin D receptor and calcium-sensing receptor in highly proliferative parathyroid adenomas","volume":"148","author":"Yano","year":"2003","journal-title":"Eur J Endocrinol"},{"issue":"Suppl 2","key":"key20180107181840_b6-ijo-45-02-0641","first-page":"N30","article-title":"Molecular pathogenesis of primary hyperparathyroidism","volume":"17","author":"Arnold","year":"2002","journal-title":"J Bone Miner Res"},{"key":"key20180107181840_b7-ijo-45-02-0641","doi-asserted-by":"crossref","first-page":"3961","DOI":"10.1210\/jcem.87.8.8759","article-title":"Loss of heterozygosity in parathyroid glands of familial hypercalcemia with hypercalciuria and point mutation in calcium receptor","volume":"87","author":"Szabo","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"key20180107181840_b8-ijo-45-02-0641","first-page":"727","article-title":"Distinct target regions for chromosome 1p deletions in parathyroid adenomas and carcinomas","volume":"21","author":"Valimaki","year":"2002","journal-title":"Int J Oncol"},{"key":"key20180107181840_b9-ijo-45-02-0641","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1046\/j.1365-2265.2002.01502.x","article-title":"Genetic analysis of the MEN1 gene and HPRT2 locus in two Italian kindreds with familial isolated hyperparathyroidism","volume":"56","author":"Cetani","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key20180107181840_b10-ijo-45-02-0641","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0304-3835(01)00729-7","article-title":"Biallelic inactivation by somatic mutations of the MEN1 gene in sporadic parathyroid tumors","volume":"175","author":"Tanaka","year":"2002","journal-title":"Cancer Lett"},{"key":"key20180107181840_b11-ijo-45-02-0641","doi-asserted-by":"crossref","first-page":"5583","DOI":"10.1210\/jc.2004-0294","article-title":"Genetic analyses of the HRPT2 gene in primary hyperparathyroidism: germline and somatic mutations in familial and sporadic parathyroid tumors","volume":"89","author":"Cetani","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"key20180107181840_b12-ijo-45-02-0641","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1086\/302259","article-title":"Hyperpara-thyroidism- jaw tumor syndrome: the HRPT2 locus is within a 0.7-cM region on chromosome 1q","volume":"64","author":"Hobbs","year":"1999","journal-title":"Am J Hum Genet"},{"key":"key20180107181840_b13-ijo-45-02-0641","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1136\/jmg.40.9.657","article-title":"HRPT2 mutations are associated with malignancy in sporadic parathyroid tumours","volume":"40","author":"Howell","year":"2003","journal-title":"J Med Genet"},{"key":"key20180107181840_b14-ijo-45-02-0641","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1056\/NEJMoa031237","article-title":"Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma","volume":"349","author":"Shattuck","year":"2003","journal-title":"N Engl J Med"},{"key":"key20180107181840_b15-ijo-45-02-0641","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1210\/jc.2004-0991","article-title":"A Novel IVS2-1G>A mutation causes aberrant splicing of the HRPT2 gene in a family with hyperparathyroidism-jaw tumor syndrome","volume":"90","author":"Moon","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"key20180107181840_b16-ijo-45-02-0641","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.ymgme.2010.03.017","article-title":"Analysis of aberrantly spliced HRPT2 transcripts and the resulting proteins in HPT-JT syndrome","volume":"100","author":"Moon","year":"2010","journal-title":"Mol Genet Metab"},{"key":"key20180107181840_b17-ijo-45-02-0641","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2212Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"key20180107181840_b18-ijo-45-02-0641","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/ng1048","article-title":"HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome","volume":"32","author":"Carpten","year":"2002","journal-title":"Nat Genet"},{"key":"key20180107181840_b19-ijo-45-02-0641","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1177\/000348940711601210","article-title":"Aberrant methylation of the HRPT2 gene in parathyroid carcinoma","volume":"116","author":"Hewitt","year":"2007","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"key20180107181840_b20-ijo-45-02-0641","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1128\/MCB.00654-07","article-title":"Parafibromin, a component of the human PAF complex, regulates growth factors and is required for embryonic development and survival in adult mice","volume":"28","author":"Wang","year":"2008","journal-title":"Mol Cell Biol"},{"key":"key20180107181840_b21-ijo-45-02-0641","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.bbamcr.2012.01.004","article-title":"Mechanisms of FGFR-mediated carcinogenesis","volume":"1823","author":"Ahmad","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"key20180107181840_b22-ijo-45-02-0641","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1242\/dev.127.3.483","article-title":"An important role for the IIIb isoform of fibroblast growth factor receptor 2 (FGFR2) in mesenchymal-epithelial signalling during mouse organogenesis","volume":"127","author":"De Moerlooze","year":"2000","journal-title":"Development"},{"key":"key20180107181840_b23-ijo-45-02-0641","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nrc2780","article-title":"Fibroblast growth factor signalling: from development to cancer","volume":"10","author":"Turner","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"key20180107181840_b24-ijo-45-02-0641","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1158\/1541-7786.MCR-10-0168","article-title":"Roles of fibroblast growth factor receptors in carcinogenesis","volume":"8","author":"Haugsten","year":"2010","journal-title":"Mol Cancer Res"},{"key":"key20180107181840_b25-ijo-45-02-0641","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1677\/erc.1.00535","article-title":"The role of fibroblast growth factors and their receptors in prostate cancer","volume":"11","author":"Kwabi-Addo","year":"2004","journal-title":"Endocr Relat Cancer"},{"key":"key20180107181840_b26-ijo-45-02-0641","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.oraloncology.2006.01.005","article-title":"Recurrent FGFR1 amplification and high FGFR1 protein expression in oral squamous cell carcinoma (OSCC)","volume":"43","author":"Freier","year":"2007","journal-title":"Oral Oncol"},{"key":"key20180107181840_b27-ijo-45-02-0641","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1371\/journal.pbio.0060108","article-title":"Allele-specific up-regulation of FGFR2 increases susceptibility to breast cancer","volume":"6","author":"Meyer","year":"2008","journal-title":"PLoS Biol"},{"key":"key20180107181840_b28-ijo-45-02-0641","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/ijc.2910590314","article-title":"Expression of the FGFR1 gene in human breast-carcinoma cells","volume":"59","author":"Jacquemier","year":"1994","journal-title":"Int J Cancer"},{"key":"key20180107181840_b29-ijo-45-02-0641","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1002\/path.2657","article-title":"Evidence for distinct alterations in the FGF axis in prostate cancer progression to an aggressive clinical phenotype","volume":"220","author":"Murphy","year":"2010","journal-title":"J Pathol"},{"key":"key20180107181840_b30-ijo-45-02-0641","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.ccr.2007.11.004","article-title":"Inducible FGFR-1 activation leads to irreversible prostate adenocarcinoma and an epithelial-to-mesenchymal transition","volume":"12","author":"Acevedo","year":"2007","journal-title":"Cancer Cell"},{"key":"key20180107181840_b31-ijo-45-02-0641","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1038\/bjc.2011.367","article-title":"Upregulated FGFR1 expression is associated with the transition of hormone-naive to castrate-resistant prostate cancer","volume":"105","author":"Armstrong","year":"2011","journal-title":"Br J Cancer"},{"key":"key20180107181840_b32-ijo-45-02-0641","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/nature05315","article-title":"Klotho converts canonical FGF receptor into a specific receptor for FGF23","volume":"444","author":"Urakawa","year":"2006","journal-title":"Nature"},{"key":"key20180107181840_b33-ijo-45-02-0641","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3389\/fendo.2012.00078","article-title":"Parathyroid diseases and animal models","volume":"3","author":"Imanishi","year":"2012","journal-title":"Front Endocrinol (Lausanne)"},{"key":"key20180107181840_b34-ijo-45-02-0641","first-page":"4003","article-title":"The parathyroid is a target organ for FGF23 in rats","volume":"117","author":"Ben-Dov","year":"2007","journal-title":"J Clin Invest"},{"key":"key20180107181840_b35-ijo-45-02-0641","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.2353\/ajpath.2010.090356","article-title":"Reduced expression of fibroblast growth factor receptor 2IIIb in hepatocellular carcinoma induces a more aggressive growth","volume":"176","author":"Amann","year":"2010","journal-title":"Am J Pathol"},{"key":"key20180107181840_b36-ijo-45-02-0641","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/sj.onc.1200830","article-title":"Decreased expression of keratinocyte growth factor receptor in a subset of human transitional cell bladder carcinomas","volume":"14","author":"Diez de Medina","year":"1997","journal-title":"Oncogene"},{"key":"key20180107181840_b37-ijo-45-02-0641","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/pros.10104","article-title":"Down-regulation of (IIIb) and (IIIc) isoforms of fibroblast growth factor receptor 2 (FGFR2) is associated with malignant progression in human prostate","volume":"52","author":"Naimi","year":"2002","journal-title":"Prostate"}],"container-title":["International Journal of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ijo.2014.2477\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T03:41:07Z","timestamp":1649130067000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ijo.2014.2477"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,29]]},"references-count":37,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2014,5,29]]},"published-print":{"date-parts":[[2014,8]]}},"alternative-id":["10.3892\/ijo.2014.2477"],"URL":"https:\/\/doi.org\/10.3892\/ijo.2014.2477","relation":{},"ISSN":["1019-6439","1791-2423"],"issn-type":[{"value":"1019-6439","type":"print"},{"value":"1791-2423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,29]]}}}